StreetInsider.com News Articles

NCR Atleos Announces Date of Third Quarter 2026 Earnings Results

Tue, 20 Oct 2026 15:40:00 -0400

ATLANTA--(BUSINESS WIRE)-- NCR Atleos Corporation (NYSE: NATL) (“Atleos”) will release third quarter 2026 financial results before the market opens on Wednesday, November 4, 2026.

Due to the pending transaction with The Brinks Company, NCR Atleos will not be hosting an earnings conference call to review the third quarter or issue a financial outlook.

About Atleos

Atleos (NYSE: NATL) is a leader in expanding self-service financial access, with industry-leading ATM expertise and experience, unrivalled operational scale including the largest independently-owned ATM network, always-on global services

NCR Atleos Announces Date of Third Quarter 2026 Earnings Results

Tue, 20 Oct 2026 15:40:00 -0400

ATLANTA--(BUSINESS WIRE)-- NCR Atleos Corporation (NYSE: NATL) (“Atleos”) will release third quarter 2026 financial results before the market opens on Wednesday, November 4, 2026.

Due to the pending transaction with The Brinks Company, NCR Atleos will not be hosting an earnings conference call to review the third quarter or issue a financial outlook.

About Atleos

Brink's gets CMA approval in principle for NCR Atleos deal remedy

Thu, 08 Oct 2026 05:10:11 -0400

The Brink's Company (NYSE: BCO) announced that the United Kingdom's Competition and Markets Authority (CMA) has accepted in principle its proposed remedy related to its planned acquisition of NCR Atleos Corporation (NYSE: NATL).

The proposed remedy involves the divestiture of NoteMachine/TestLink UK, which Brink's says would serve as an undertaking in lieu of a Phase 2 investigation referral by the CMA. Brink's stated it is engaged with prospective buyers and is working to conclude the divestiture in a timely manner.

According to Brink's President and Chief Executive Officer Mark Eubanks, the potential sale of NoteMachine/TestLink UK "was a remedy that was contemplated

Brink's gets CMA approval in principle for NCR Atleos deal remedy

Thu, 08 Oct 2026 05:10:11 -0400

According to Brink's President and Chief Executive Officer Mark Eubanks, the potential sale of NoteMachine/TestLink UK "was a remedy that was contemplated

Brink's gets UK antitrust approval to divest unit in NCR Atleos deal

Thu, 08 Oct 2026 05:09:33 -0400

The Brink's Company (NYSE: BCO) announced that the United Kingdom's Competition and Markets Authority (CMA) has accepted in principle its proposed remedy for the planned acquisition of NCR Atleos Corporation (NYSE: NATL).

The remedy involves the divestiture of NoteMachine/TestLink UK, which Brink's proposed as an alternative to a Phase 2 investigation by the CMA. Brink's stated it is working to select a suitable buyer and complete the divestiture process in a timely manner. As of Sept. 30, 2026, Brink's said the sale process was progressing and that it remained engaged with a number of prospective buyers.

Mark Eubanks, President and Chief Executive

Brink's gets UK antitrust approval to divest unit in NCR Atleos deal

Thu, 08 Oct 2026 05:09:33 -0400

Mark Eubanks, President and Chief Executive

Brink's Receives CMA Acceptance in Principle of Proposed Remedy Relating to Pending Acquisition of NCR Atleos

Thu, 08 Oct 2026 05:09:20 -0400

Divestiture of NoteMachine/TestLink UK to avoid a CMA Phase 2 referral

Acquisition of NCR Atleos remains on track to close early in the first quarter of 2027

RICHMOND, Va., Oct. 08, 2026 (GLOBE NEWSWIRE) -- The Brink's Company (NYSE: BCO) (“Brink’s” or “the Company”) announced today that the United Kingdom's Competition and Markets Authority ("CMA") has accepted in principle Brink’s proposed remedy for its planned acquisition of NCR Atleos Corporation (NYSE: NATL) (“NCR Atleos”).

Brink's has been working constructively with the CMA to establish that the divestiture of NoteMachine/TestLink UK is

Brink's Receives CMA Acceptance in Principle of Proposed Remedy Relating to Pending Acquisition of NCR Atleos

Thu, 08 Oct 2026 05:09:20 -0400

Divestiture of NoteMachine/TestLink UK to avoid a CMA Phase 2 referral

Acquisition of NCR Atleos remains on track to close early in the first quarter of 2027

Brink's has been working constructively with the CMA to establish that the divestiture of NoteMachine/TestLink UK is

Brink's Receives CMA Acceptance in Principle of Proposed Remedy Relating to Pending Acquisition of NCR Atleos

Thu, 08 Oct 2026 05:09:20 -0400

Divestiture of NoteMachine/TestLink UK to avoid a CMA Phase 2 referral

Acquisition of NCR Atleos remains on track to close early in the first quarter of 2027

Brink's has been working constructively with the CMA to establish that the divestiture of NoteMachine/TestLink UK is

Brink's Receives CMA Acceptance in Principle of Proposed Remedy Relating to Pending Acquisition of NCR Atleos

Thu, 08 Oct 2026 05:09:20 -0400

Divestiture of NoteMachine/TestLink UK to avoid a CMA Phase 2 referral

Acquisition of NCR Atleos remains on track to close early in the first quarter of 2027

Brink's has been working constructively with the CMA to establish that the divestiture of NoteMachine/TestLink UK is

Brink's Receives CMA Acceptance in Principle of Proposed Remedy Relating to Pending Acquisition of NCR Atleos

Thu, 08 Oct 2026 05:09:00 -0400

Divestiture of NoteMachine/TestLink UK to avoid a CMA Phase 2 referral

Acquisition of NCR Atleos remains on track to close early in the first quarter of 2027

Brink's has been working constructively with the CMA to establish that the divestiture of NoteMachine/TestLink UK is

Brink's Receives CMA Acceptance in Principle of Proposed Remedy Relating to Pending Acquisition of NCR Atleos

Thu, 08 Oct 2026 05:09:00 -0400

Divestiture of NoteMachine/TestLink UK to avoid a CMA Phase 2 referral

Acquisition of NCR Atleos remains on track to close early in the first quarter of 2027

Brink's has been working constructively with the CMA to establish that the divestiture of NoteMachine/TestLink UK is

Brink's Receives CMA Acceptance in Principle of Proposed Remedy Relating to Pending Acquisition of NCR Atleos

Thu, 08 Oct 2026 05:09:00 -0400

Divestiture of NoteMachine/TestLink UK to avoid a CMA Phase 2 referral

Acquisition of NCR Atleos remains on track to close early in the first quarter of 2027

Brink's has been working constructively with the CMA to establish that the divestiture of NoteMachine/TestLink UK is

Brink's Receives CMA Acceptance in Principle of Proposed Remedy Relating to Pending Acquisition of NCR Atleos

Thu, 08 Oct 2026 05:09:00 -0400

Divestiture of NoteMachine/TestLink UK to avoid a CMA Phase 2 referral

Acquisition of NCR Atleos remains on track to close early in the first quarter of 2027

Brink's has been working constructively with the CMA to establish that the divestiture of NoteMachine/TestLink UK is

Form 4 NCR Atleos Corp For: Oct 01 Filed by: NUNEZ RICARDO J

Fri, 02 Oct 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20261002/27142315.html

Form 4 NCR Atleos Corp For: Sep 30 Filed by: Reece Joseph E

Fri, 02 Oct 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20261002/27142185.html

Brink's to divest UK unit amid CMA review of NCR Atleos deal

Wed, 30 Sep 2026 15:59:25 -0400

The Brink's Company (NYSE: BCO) said it will propose the divestiture of its NoteMachine/TestLink UK business as part of a Phase 1 review by the United Kingdom's Competition and Markets Authority related to its planned acquisition of NCR Atleos Corporation (NYSE: NATL).

The CMA issued its Phase 1 decision under a "fast-track" procedure, citing overlap between Brink's NoteMachine/TestLink UK operations and NCR Atleos' Cardtronics business in the UK. Brink's said the potential sale of NoteMachine/TestLink UK was already factored into previously disclosed financial metrics for the transaction.

According to a company statement, the divestiture would not affect the $200 million in annual

Brink's to divest UK unit amid CMA review of NCR Atleos deal

Wed, 30 Sep 2026 15:59:25 -0400

According to a company statement, the divestiture would not affect the $200 million in annual

Brink's to divest UK unit amid CMA review of NCR Atleos deal

Wed, 30 Sep 2026 15:59:25 -0400

According to a company statement, the divestiture would not affect the $200 million in annual

Brink's to divest UK unit amid CMA review of NCR Atleos deal

Wed, 30 Sep 2026 15:59:25 -0400

According to a company statement, the divestiture would not affect the $200 million in annual

Brink's Issues Statement on CMA’s Fast-Track Announcement

Wed, 30 Sep 2026 15:54:00 -0400

Company agrees to propose divestiture of NoteMachine/TestLink UK in connection with CMA review

Acquisition of NCR Atleos remains on track to close early in the first quarter of 2027

RICHMOND, Va., Sept. 30, 2026 (GLOBE NEWSWIRE) -- The Brink's Company (NYSE: BCO) (“Brink’s” or “the Company”) today issued the following statement in connection with the United Kingdom's Competition and Markets Authority ("CMA") Phase 1 decision in relation to the Company’s previously announced agreement to acquire NCR Atleos Corporation (NYSE: NATL) (“NCR Atleos”):

“The CMA’s Phase 1 decision was always contemplated

Brink's Issues Statement on CMA’s Fast-Track Announcement

Wed, 30 Sep 2026 15:54:00 -0400

Company agrees to propose divestiture of NoteMachine/TestLink UK in connection with CMA review

Acquisition of NCR Atleos remains on track to close early in the first quarter of 2027

RICHMOND, Va., Sept. 30, 2026 (GLOBE NEWSWIRE) -- The Brink's Company (NYSE: BCO) (“Brink’s” or “the Company”) today issued the following statement in connection with the United Kingdom's Competition and Markets Authority ("CMA") Phase 1 decision in relation to the Company’s previously announced agreement to acquire NCR Atleos Corporation (NYSE: NATL) (“NCR Atleos”):

“The CMA’s Phase 1 decision was always contemplated

Brink's Issues Statement on CMA’s Fast-Track Announcement

Wed, 30 Sep 2026 15:54:00 -0400

Company agrees to propose divestiture of NoteMachine/TestLink UK in connection with CMA review

Acquisition of NCR Atleos remains on track to close early in the first quarter of 2027

RICHMOND, Va., Sept. 30, 2026 (GLOBE NEWSWIRE) -- The Brink's Company (NYSE: BCO) (“Brink’s” or “the Company”) today issued the following statement in connection with the United Kingdom's Competition and Markets Authority ("CMA") Phase 1 decision in relation to the Company’s previously announced agreement to acquire NCR Atleos Corporation (NYSE: NATL) (“NCR Atleos”):

“The CMA’s Phase 1 decision was always contemplated

Brink's Issues Statement on CMA’s Fast-Track Announcement

Wed, 30 Sep 2026 15:54:00 -0400

Company agrees to propose divestiture of NoteMachine/TestLink UK in connection with CMA review

Acquisition of NCR Atleos remains on track to close early in the first quarter of 2027

RICHMOND, Va., Sept. 30, 2026 (GLOBE NEWSWIRE) -- The Brink's Company (NYSE: BCO) (“Brink’s” or “the Company”) today issued the following statement in connection with the United Kingdom's Competition and Markets Authority ("CMA") Phase 1 decision in relation to the Company’s previously announced agreement to acquire NCR Atleos Corporation (NYSE: NATL) (“NCR Atleos”):

“The CMA’s Phase 1 decision was always contemplated

Brink's Issues Statement on CMA’s Fast-Track Announcement

Wed, 30 Sep 2026 15:54:00 -0400

Company agrees to propose divestiture of NoteMachine/TestLink UK in connection with CMA review

Acquisition of NCR Atleos remains on track to close early in the first quarter of 2027

RICHMOND, Va., Sept. 30, 2026 (GLOBE NEWSWIRE) -- The Brink's Company (NYSE: BCO) (“Brink’s” or “the Company”) today issued the following statement in connection with the United Kingdom's Competition and Markets Authority ("CMA") Phase 1 decision in relation to the Company’s previously announced agreement to acquire NCR Atleos Corporation (NYSE: NATL) (“NCR Atleos”):

“The CMA’s Phase 1 decision was always contemplated